Provided by Tiger Trade Technology Pte. Ltd.

Celcuity Inc

93.53
+2.963.27%
Pre-market: 93.940.4100+0.44%07:39 EDT
Volume:889.30K
Turnover:83.43M
Market Cap:4.56B
PE:-21.64
High:95.46
Open:91.39
Low:90.51
Close:90.57
52wk High:151.02
52wk Low:44.42
Shares:48.77M
Float Shares:29.72M
Volume Ratio:1.04
T/O Rate:2.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3223
EPS(LYR):-3.7900
ROE:-1433.70%
ROA:-25.78%
PB:-356.87
PE(LYR):-24.68

Loading ...

Shares of Celcuity up 1.6% After Boosted $500 Mln Convertible Bond Offering

THOMSON REUTERS
·
Jun 04

Celcuity prices $500M convertible senior note offering

TIPRANKS
·
Jun 04

Celcuity Trial Win Raises Questions On Risk, Value And Next Steps

Simply Wall St.
·
Jun 04

Celcuity Inc. Prices Upsized $500 Million 0.25% Convertible Senior Notes Due 2032

Reuters
·
Jun 04

Movement Alert|Celcuity Falls 8.19% in Regular Trading, Convertible Notes Offering Adds Pressure After Post-Data Selloff

Market Focus
·
Jun 04

BUZZ-U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway

Reuters
·
Jun 03

BUZZ-Celcuity drops further after announcing $400 mln convertible offering

Reuters
·
Jun 03

Celcuity Plans $400 Million Convertible Notes Offering

MT Newswires Live
·
Jun 03

Celcuity Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 03

Celcuity Inc. Announces Public Offering Of Convertible Senior Notes Due 2032

Reuters
·
Jun 03

BRIEF-Celcuity - Offering $400 Million Convertible Senior Notes Due 2032 - SEC Filing

Reuters
·
Jun 03

Celcuity launches USD 400 million convertible senior notes offering due 2032

Reuters
·
Jun 03

Celcuity Inc. Announces Public Offering of Convertible Senior Notes Due 2032

GlobeNewswire
·
Jun 03

Celcuity - Offering $400 Mln Convertible Senior Notes Due 2032 - SEC Filing

THOMSON REUTERS
·
Jun 03

Celcuity price target lowered to $145 from $185 at H.C. Wainwright

TIPRANKS
·
Jun 03

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Gilead Sciences (GILD) and Celcuity (CELC)

TIPRANKS
·
Jun 03

U.S. RESEARCH ROUNDUP-Aveanna Healthcare, Palo Alto, Ulta Beauty

Reuters
·
Jun 03

Celcuity Says Gedatolisib Outperforms Novartis' Alpelisib Plus Fulvestrant in Phase 3 Trial

MT Newswires Live
·
Jun 03

Analysts Offer Insights on Healthcare Companies: Disc Medicine (IRON) and Celcuity (CELC)

TIPRANKS
·
Jun 03

Celcuity plunges after experimental breast cancer treatment data disappoints

Reuters
·
Jun 03